Literature DB >> 33007778

Multimodal investigation of dopamine D2/D3 receptors, default mode network suppression, and cognitive control in cocaine-use disorder.

Patrick D Worhunsky1, Gustavo A Angarita2, Zu Wei Zhai3, David Matuskey2,4, Jean-Dominique Gallezot4, Robert T Malison2,5, Richard E Carson4, Marc N Potenza2,5,6,7.   

Abstract

Stimulant-use disorders have been associated with lower availability of dopamine type-2 receptors (D2R) and greater availability of type-3 receptors (D3R). Links between D2R levels, cognitive performance, and suppression of the default mode network (DMN) during executive functioning have been observed in healthy and addicted populations; however, there is limited evidence regarding a potential role of elevated D3R in influencing cognitive control processes in groups with and without addictions. Sixteen individuals with cocaine-use disorder (CUD) and 16 healthy comparison (HC) participants completed [11C]-(+)-PHNO PET imaging of D2R and D3R availability and fMRI during a Stroop task of cognitive control. Independent component analysis was performed on fMRI data to assess DMN suppression during Stroop performance. In HC individuals, lower D2R-related binding in the dorsal putamen was associated with improved task performance and greater DMN suppression. By comparison, in individuals with CUD, greater D3R-related binding in the substantia nigra was associated with improved performance and greater DMN suppression. Exploratory moderated-mediation analyses indicated that DMN suppression was associated with Stroop performance indirectly through D2R in HC and D3R in CUD participants, and these indirect effects were different between groups. To our knowledge, this is the first evidence of a dissociative and potentially beneficial role of elevated D3R availability in executive functioning in cocaine-use disorder.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33007778      PMCID: PMC7852666          DOI: 10.1038/s41386-020-00874-7

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  69 in total

Review 1.  Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors.

Authors:  Philip Seeman
Journal:  Synapse       Date:  2015-02-03       Impact factor: 2.562

2.  Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study.

Authors:  Isabelle Boileau; Doris Payer; Sylvain Houle; Arian Behzadi; Pablo M Rusjan; Junchao Tong; Diana Wilkins; Peter Selby; Tony P George; Martin Zack; Yoshiaki Furukawa; Tina McCluskey; Alan A Wilson; Stephen J Kish
Journal:  J Neurosci       Date:  2012-01-25       Impact factor: 6.167

Review 3.  The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence.

Authors:  Christian A Heidbreder; Eliot L Gardner; Zheng-Xiong Xi; Panayotis K Thanos; Manolo Mugnaini; Jim J Hagan; Charles R Ashby
Journal:  Brain Res Brain Res Rev       Date:  2005-07

4.  Dopaminergic network differences in human impulsivity.

Authors:  Joshua W Buckholtz; Michael T Treadway; Ronald L Cowan; Neil D Woodward; Rui Li; M Sib Ansari; Ronald M Baldwin; Ashley N Schwartzman; Evan S Shelby; Clarence E Smith; Robert M Kessler; David H Zald
Journal:  Science       Date:  2010-07-30       Impact factor: 47.728

5.  Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction.

Authors:  Nora D Volkow; Gene-Jack Wang; Frank Telang; Joanna S Fowler; Jean Logan; Anna-Rose Childress; Millard Jayne; Yeming Ma; Christopher Wong
Journal:  J Neurosci       Date:  2006-06-14       Impact factor: 6.167

6.  Dopamine D₃ receptor alterations in cocaine-dependent humans imaged with [¹¹C](+)PHNO.

Authors:  David Matuskey; Jean-Dominique Gallezot; Brian Pittman; Wendol Williams; Jane Wanyiri; Edward Gaiser; Dianne E Lee; Jonas Hannestad; Keunpoong Lim; Minq-Qiang Zheng; Shu-fei Lin; David Labaree; Marc N Potenza; Richard E Carson; Robert T Malison; Yu-Shin Ding
Journal:  Drug Alcohol Depend       Date:  2014-03-20       Impact factor: 4.492

7.  Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects.

Authors:  N D Volkow; G J Wang; J S Fowler; J Logan; S J Gatley; R Hitzemann; A D Chen; S L Dewey; N Pappas
Journal:  Nature       Date:  1997-04-24       Impact factor: 49.962

Review 8.  Imaging dopamine's role in drug abuse and addiction.

Authors:  N D Volkow; J S Fowler; G J Wang; R Baler; F Telang
Journal:  Neuropharmacology       Date:  2008-06-03       Impact factor: 5.250

9.  Regional and source-based patterns of [11C]-(+)-PHNO binding potential reveal concurrent alterations in dopamine D2 and D3 receptor availability in cocaine-use disorder.

Authors:  Patrick D Worhunsky; David Matuskey; Jean-Dominique Gallezot; Edward C Gaiser; Nabeel Nabulsi; Gustavo A Angarita; Vince D Calhoun; Robert T Malison; Marc N Potenza; Richard E Carson
Journal:  Neuroimage       Date:  2017-01-19       Impact factor: 6.556

Review 10.  The dopamine theory of addiction: 40 years of highs and lows.

Authors:  David J Nutt; Anne Lingford-Hughes; David Erritzoe; Paul R A Stokes
Journal:  Nat Rev Neurosci       Date:  2015-04-15       Impact factor: 34.870

View more
  4 in total

1.  Longitudinal changes in network engagement during cognitive control in cocaine use disorder.

Authors:  Kristen P Morie; Elise E DeVito; Marc N Potenza; Patrick D Worhunsky
Journal:  Drug Alcohol Depend       Date:  2021-10-30       Impact factor: 4.492

2.  Behavioral Inflexibility from a Neuronal Population Perspective.

Authors:  Jinkang Xiang; Yilin Chen; Megan Roussy
Journal:  J Neurosci       Date:  2021-06-23       Impact factor: 6.167

3.  Effects of chronic cocaine and ethanol self-administration on brain dopamine receptors in a rhesus monkey model of polysubstance abuse.

Authors:  Felicity M Say; Aaron M Tryhus; Phillip M Epperly; Susan H Nader; Kiran K Solingapuram Sai; Brianna E George; Haley A Kirse; Paul W Czoty
Journal:  Addict Biol       Date:  2022-09       Impact factor: 4.093

Review 4.  Can pharmacotherapy improve treatment outcomes in people with co-occurring major depressive and cocaine use disorders?

Authors:  Gustavo A Angarita; Hasti Hadizadeh; Ignacio Cerdena; Marc N Potenza
Journal:  Expert Opin Pharmacother       Date:  2021-06-23       Impact factor: 4.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.